High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma
Keywords
Low grade serous ovarian carcinoma
Ovarian cancer
High throughput screen
Dasatinib
Disulfiram
Src family kinases
Drug repurposing
Cancer therapy
Data availability
We are happy to provide all data presented in this manuscript upon reasonable request to the corresponding author.
© 2024 The Author(s). Published by Elsevier Inc.
留言 (0)